Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation CCVVC 2016

Pathology of Drug Eluting Technologies: Are There Differences?

Presenter: Renu Virmani

June 15, 2016

Presentation CADECI 2015

The future of Drug-Eluting Stent

Presenter: Renu Virmani

February 18, 2015

Presentation TCT 2014

Differences Between Polymeric and Metallic Bioresorbable Scaffolds

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Ron Waksman

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Yoshinobu Onuma

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: Biomechanics and Vascular Responses

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Juan F. Granada

September 16, 2014

Presentation TCT 2014

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Stephen G. Ellis

September 16, 2014

Presentation TCT 2014

Comparison of Current-Generation Metallic DES with BMS and First-Generation DES: Pathologic Progress and Remaining Challenges

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Renu Virmani

September 14, 2014

Presentation TCT 2014

Case #2: A Patient Who Might Especially Benefit from the COBRA PzF-Shielded Stent

Presenter: Renu Virmani

September 13, 2014

Presentation TCT 2014

The Concept of the COBRA PzF-Shielded Stent

Presenter: Renu Virmani, Donald Cutlip

September 13, 2014

Presentation TCT 2013

Vascular Responses of Contemporary Durable Polymer DES, Bioabsorbable Polymer DES, Polymer-free DES and Fully Bioresorbable Scaffolds: Can Meaningful Differences in Vascular...

Presenter: Renu Virmani

October 27, 2013

Presentation TCT 2013

Impact of Varying Injury Severity and Multiple Treatments on Arterial Histopathology Early After Paclitaxel Coated Balloon Treatment of the Iliofemoral Arteries of Domestic Swine

Presenter: Maxwell Afari, Armando Tellez, Seung-Jin Oh, Krzysztof Milewski, Piotr Buszman, Renu Virmani, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2012

Paclitaxel Delivery and Tissue Effects: Similarities and Critical Differences with DES

Presenter: Renu Virmani

October 25, 2012

Presentation TCT 2012

Vascular Healing and the Evolution of DES Technologies: Pathology Insights from Human Specimens

Presenter: Renu Virmani

October 23, 2012

Presentation GI2 2012

Pathology of DES with Biodegradable Polymer: Are They Really Better?

Presenter: Renu Virmani

April 12, 2012

Presentation TCT 2012

An All Comers Randomized Trial Comparing Xience Prime and Promus Element Stents. Preliminary Results.

Presenter: Jose M. De la Torre Hernandez, Tamara Garcia Camarero, Piedad Lerena, Dae-Hyun Lee, Fermin Sainz Laso, Virginia Frances Santamaria, Monica Fernandez Menendez, Gonzalo Martin Gorria, Javier Zueco

January 03, 2012

Advertisement

Pathology of Drug Eluting Technologies: Are There Differences?

The future of Drug-Eluting Stent

Differences Between Polymeric and Metallic Bioresorbable Scaffolds

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Scaffolds vs Stents: Biomechanics and Vascular Responses

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Comparison of Current-Generation Metallic DES with BMS and First-Generation DES: Pathologic Progress and Remaining Challenges

Case #2: A Patient Who Might Especially Benefit from the COBRA PzF-Shielded Stent

The Concept of the COBRA PzF-Shielded Stent

Vascular Responses of Contemporary Durable Polymer DES, Bioabsorbable Polymer DES, Polymer-free DES and Fully Bioresorbable Scaffolds: Can Meaningful Differences in Vascular...

Impact of Varying Injury Severity and Multiple Treatments on Arterial Histopathology Early After Paclitaxel Coated Balloon Treatment of the Iliofemoral Arteries of Domestic Swine

Paclitaxel Delivery and Tissue Effects: Similarities and Critical Differences with DES

Vascular Healing and the Evolution of DES Technologies: Pathology Insights from Human Specimens

Pathology of DES with Biodegradable Polymer: Are They Really Better?

An All Comers Randomized Trial Comparing Xience Prime and Promus Element Stents. Preliminary Results.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content